Abbott Laboratories (Pakistan) Limited (PSX:ABOT)

Market Cap	105.15B
Revenue (ttm)	74.84B
Net Income (ttm)	6.65B
Shares Out	97.90M
EPS (ttm)	67.93
PE Ratio	15.81
Forward PE	14.94
Dividend	10.00 (0.91%)
Ex-Dividend Date	Apr 14, 2025

Volume	4,032
Average Volume	14,947
Open	1,100.00
Previous Close	1,099.39
Day's Range	1,059.00 - 1,108.30
52-Week Range	790.00 - 1,310.00
Beta	0.08
RSI	27.35
Earnings Date	Oct 29, 2025

About PSX:ABOT

Abbott Laboratories (Pakistan) Limited manufactures, imports, and markets generic pharmaceutical, nutritional, diagnostic, diabetes care, molecular devices, hospital, and consumer products in Pakistan, Afghanistan, Sri Lanka, Bangladesh, and Switzerland. It operates through Pharmaceutical, Nutritional, Diagnostics, and Others segments. The company engages in the manufacturing, importing, and marketing of branded generic pharmaceutical products; AND import and marketing of nutritional products. It imports and markets diagnostic equipment, molecu...

• Industry: Pharmaceuticals
• Sector: Healthcare
• Founded: 1888
• Employees: 1,406
• Stock Exchange: Pakistan Stock Exchange
• Ticker Symbol: ABOT

Financial Performance

In 2024, PSX:ABOT's revenue was 68.18 billion, an increase of 22.90% compared to the previous year's 55.48 billion. Earnings were 5.23 billion, an increase of 1899.50%.